Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)
Compose a Response to This Article
Other responses
No responses have been published for this article.
